España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Zymeworks
ZYME
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$14.60
-0.14
-0.95%
At close: -
$14.60
0.00
0.00%
After Hours: Jan 31, 4:00 PM EDT
Get Report
Comment
Zymeworks (ZYME) Forecast
News
Earnings
Zymeworks (ZYME) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Zymeworks (NASDAQ:ZYME) Stock
Zymeworks Stock (NASDAQ: ZYME)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, January 23, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, January 08, 2025
Zymeworks Expects $324M Cash Resources, Plus ...
Benzinga Newsdesk
Thursday, December 19, 2024
Deep Dive Into Zymeworks Stock: Analyst Perspectives (10 Ratings)
Benzinga Insights
Wells Fargo Maintains Equal-Weight on Zymewor...
Benzinga Newsdesk
Monday, December 16, 2024
Zymeworks shares are trading higher after JP ...
Benzinga Newsdesk
JP Morgan Upgrades Zymeworks to Overweight, A...
Benzinga Newsdesk
Thursday, December 12, 2024
Zymeworks Hosts R&D Day Highlighting Continue...
Benzinga Newsdesk
Friday, November 22, 2024
In-Depth Examination Of 9 Analyst Recommendations For Zymeworks
Benzinga Insights
HC Wainwright & Co. Reiterates Neutral on Zym...
Benzinga Newsdesk
Thursday, November 21, 2024
FDA Greenlights Jazz Pharma's Cancer Drug, A Milestone For Zymework
Vandana Singh
Jazz Pharmaceuticals and Zymeworks shares are...
Benzinga Newsdesk
Reported Earlier, Jazz Pharmaceuticals Secure...
Benzinga Newsdesk
Thursday, November 07, 2024
Sarepta Therapeutics To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
Leerink Partners Upgrades Zymeworks to Outper...
Benzinga Newsdesk
Tuesday, November 05, 2024
Zymeworks Begins Human Trials for New Cancer ...
Benzinga Newsdesk
Monday, November 04, 2024
Citigroup Maintains Buy on Zymeworks, Raises ...
Benzinga Newsdesk
Friday, November 01, 2024
HC Wainwright & Co. Reiterates Neutral on Zym...
Benzinga Newsdesk
Wells Fargo Downgrades Zymeworks to Equal-Wei...
Benzinga Newsdesk
Thursday, October 31, 2024
Zymeworks Q3 2024 GAAP EPS $(0.39) Beats $(0....
Benzinga Newsdesk
Monday, October 28, 2024
Stifel Maintains Buy on Zymeworks, Raises Pri...
Benzinga Newsdesk
Friday, October 25, 2024
Zymeworks Announced New Preclinical Data For ...
Nabaparna Bhattacharya
Tuesday, October 22, 2024
What Analysts Are Saying About Zymeworks Stock
Benzinga Insights
HC Wainwright & Co. Reiterates Neutral on Zym...
Benzinga Newsdesk
Monday, October 21, 2024
ZymeWorks Has Dosed The First Patient In The ...
Benzinga Newsdesk
Wednesday, September 25, 2024
HC Wainwright & Co. Maintains Neutral on Zyme...
Benzinga Newsdesk
Wednesday, September 18, 2024
HC Wainwright & Co. Reiterates Neutral on Zym...
Benzinga Newsdesk
Zymeworks Announced Two Presentations Highlig...
Benzinga Newsdesk
Friday, August 02, 2024
Stifel Maintains Buy on Zymeworks, Raises Pri...
Benzinga Newsdesk
Zymeworks Files For Common Stock Offering Of ...
Benzinga Newsdesk
Thursday, August 01, 2024
Zymeworks Announces Share Repurchase Program ...
Benzinga Newsdesk
Zymeworks Q2 2024 GAAP EPS $(0.49) Misses $0....
Benzinga Newsdesk
Thursday, July 25, 2024
Zymeworks Appoints Leone Patterson As Executi...
Benzinga Newsdesk
Monday, July 22, 2024
Zymeworks Says FDA Has Cleared Investigationa...
Benzinga Newsdesk
Monday, June 17, 2024
Market-Moving News for June 17th
Benzinga Newsdesk
Zymeworks shares are trading higher after the...
Benzinga Newsdesk
FDA Clears Zymeworks' Investigational New Dru...
Benzinga Newsdesk
Monday, June 10, 2024
Zymeworks Achieves Key Milestone with BLA Acc...
Benzinga Newsdesk
Thursday, June 06, 2024
Navigating 6 Analyst Ratings For Zymeworks
Benzinga Insights
HC Wainwright & Co. Reiterates Neutral on Zym...
Benzinga Newsdesk
Tuesday, May 07, 2024
Zymeworks Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Benzinga Insights
HC Wainwright & Co. Reiterates Neutral on Zym...
Benzinga Newsdesk
Friday, May 03, 2024
Citigroup Maintains Buy on Zymeworks, Lowers ...
Benzinga Newsdesk
Wells Fargo Maintains Overweight on Zymeworks...
Benzinga Newsdesk
Thursday, May 02, 2024
Zymeworks Q1 2024 GAAP EPS $(0.42) Misses $(0...
Benzinga Newsdesk
Monday, April 08, 2024
Zymeworks Presents New Data from Multiple Pre...
Benzinga Newsdesk
Tuesday, March 12, 2024
Wells Fargo Maintains Overweight on Zymeworks...
Benzinga Newsdesk
Monday, March 11, 2024
HC Wainwright & Co. Maintains Neutral on Zyme...
Benzinga Newsdesk
Wednesday, March 06, 2024
Zymeworks Q4 Adj EPS $(0.16) Beats $(0.43) Es...
Benzinga Newsdesk
Earnings Scheduled For March 6, 2024
Benzinga Insights
Tuesday, March 05, 2024
Zymeworks To Present Preclinical Data On Anti...
Benzinga Newsdesk
Show More
